These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 12853316

  • 1. Poly(ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: a strategy for neuroprotection.
    Skaper SD.
    Ann N Y Acad Sci; 2003 May; 993():217-28; discussion 287-8. PubMed ID: 12853316
    [Abstract] [Full Text] [Related]

  • 2. Poly(ADP-ribosyl)ation enzyme-1 as a target for neuroprotection in acute central nervous system injury.
    Skaper SD.
    Curr Drug Targets CNS Neurol Disord; 2003 Oct; 2(5):279-91. PubMed ID: 14529360
    [Abstract] [Full Text] [Related]

  • 3. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ, Bourgeois M, Harbison RD.
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [Abstract] [Full Text] [Related]

  • 4. Poly(ADP-ribose) polymerase: killer or conspirator? The 'suicide hypothesis' revisited.
    Chiarugi A.
    Trends Pharmacol Sci; 2002 Mar; 23(3):122-9. PubMed ID: 11879679
    [Abstract] [Full Text] [Related]

  • 5. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
    Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA.
    J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
    [Abstract] [Full Text] [Related]

  • 6. The role of poly(ADP-ribose) polymerase-1 in CNS disease.
    Kauppinen TM, Swanson RA.
    Neuroscience; 2007 Apr 14; 145(4):1267-72. PubMed ID: 17084037
    [Abstract] [Full Text] [Related]

  • 7. Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.
    Komjáti K, Besson VC, Szabó C.
    Curr Drug Targets CNS Neurol Disord; 2005 Apr 14; 4(2):179-94. PubMed ID: 15857303
    [Abstract] [Full Text] [Related]

  • 8. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
    Virág L.
    Curr Vasc Pharmacol; 2005 Jul 14; 3(3):209-14. PubMed ID: 16026317
    [Abstract] [Full Text] [Related]

  • 9. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A, Tojo N, Matsuura S, Yamazaki S, Kamijo K, Ishida J, Yamamoto H, Hattori K, Matsuoka N, Mutoh S.
    J Pharmacol Exp Ther; 2004 Aug 14; 310(2):425-36. PubMed ID: 15075382
    [Abstract] [Full Text] [Related]

  • 10. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.
    Dantzer F, Amé JC, Schreiber V, Nakamura J, Ménissier-de Murcia J, de Murcia G.
    Methods Enzymol; 2006 Aug 14; 409():493-510. PubMed ID: 16793420
    [Abstract] [Full Text] [Related]

  • 11. Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1.
    Ullrich O, Diestel A, Eyüpoglu IY, Nitsch R.
    Nat Cell Biol; 2001 Dec 14; 3(12):1035-42. PubMed ID: 11781564
    [Abstract] [Full Text] [Related]

  • 12. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.
    Virág L, Szabó C.
    Pharmacol Rev; 2002 Sep 14; 54(3):375-429. PubMed ID: 12223530
    [Abstract] [Full Text] [Related]

  • 13. Spatial and functional relationship between poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in the brain.
    Poitras MF, Koh DW, Yu SW, Andrabi SA, Mandir AS, Poirier GG, Dawson VL, Dawson TM.
    Neuroscience; 2007 Aug 10; 148(1):198-211. PubMed ID: 17640816
    [Abstract] [Full Text] [Related]

  • 14. NAD+ as a metabolic link between DNA damage and cell death.
    Ying W, Alano CC, Garnier P, Swanson RA.
    J Neurosci Res; 2007 Aug 10; 79(1-2):216-23. PubMed ID: 15562437
    [Abstract] [Full Text] [Related]

  • 15. Poly(ADP-ribose) polymerase: the nuclear target in signal transduction and its role in brain ischemia-reperfusion injury.
    Strosznajder RP, Jesko H, Zambrzycka A.
    Mol Neurobiol; 2005 Aug 10; 31(1-3):149-67. PubMed ID: 15953818
    [Abstract] [Full Text] [Related]

  • 16. Pathophysiologic role of oxidative stress-induced poly(ADP-ribose) polymerase-1 activation: focus on cell death and transcriptional regulation.
    Erdélyi K, Bakondi E, Gergely P, Szabó C, Virág L.
    Cell Mol Life Sci; 2005 Apr 10; 62(7-8):751-9. PubMed ID: 15868400
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of poly(ADP-ribose) polymerase activity protects hippocampal cells against morphological and ultrastructural alteration evoked by ischemia-reperfusion injury.
    Strosznajder R, Gadamski R, Walski M.
    Folia Neuropathol; 2005 Apr 10; 43(3):156-65. PubMed ID: 16245211
    [Abstract] [Full Text] [Related]

  • 18. Minocycline protects cardiac myocytes against simulated ischemia–reperfusion injury by inhibiting poly(ADP-ribose) polymerase-1.
    Tao R, Kim SH, Honbo N, Karliner JS, Alano CC.
    J Cardiovasc Pharmacol; 2010 Dec 10; 56(6):659-68. PubMed ID: 20881608
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modulation of transcription by PARP-1: consequences in carcinogenesis and inflammation.
    Aguilar-Quesada R, Muñoz-Gámez JA, Martín-Oliva D, Peralta-Leal A, Quiles-Pérez R, Rodríguez-Vargas JM, Ruiz de Almodóvar M, Conde C, Ruiz-Extremera A, Oliver FJ.
    Curr Med Chem; 2007 Dec 10; 14(11):1179-87. PubMed ID: 17504138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.